271 related articles for article (PubMed ID: 21059912)
1. Building multifunctionality into a complex containing master regulators of hematopoiesis.
Fujiwara T; Lee HY; Sanalkumar R; Bresnick EH
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20429-34. PubMed ID: 21059912
[TBL] [Abstract][Full Text] [Related]
2. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
3. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes.
Tripic T; Deng W; Cheng Y; Zhang Y; Vakoc CR; Gregory GD; Hardison RC; Blobel GA
Blood; 2009 Mar; 113(10):2191-201. PubMed ID: 19011221
[TBL] [Abstract][Full Text] [Related]
4. A positive role for NLI/Ldb1 in long-range beta-globin locus control region function.
Song SH; Hou C; Dean A
Mol Cell; 2007 Dec; 28(5):810-22. PubMed ID: 18082606
[TBL] [Abstract][Full Text] [Related]
5. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
6. The Hematopoietic Stem and Progenitor Cell Cistrome: GATA Factor-Dependent cis-Regulatory Mechanisms.
Hewitt KJ; Johnson KD; Gao X; Keles S; Bresnick EH
Curr Top Dev Biol; 2016; 118():45-76. PubMed ID: 27137654
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of the role of LMO2 in human erythroid cells.
Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
[TBL] [Abstract][Full Text] [Related]
8. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
[TBL] [Abstract][Full Text] [Related]
9. Distinct Ldb1/NLI complexes orchestrate γ-globin repression and reactivation through ETO2 in human adult erythroid cells.
Kiefer CM; Lee J; Hou C; Dale RK; Lee YT; Meier ER; Miller JL; Dean A
Blood; 2011 Dec; 118(23):6200-8. PubMed ID: 22010104
[TBL] [Abstract][Full Text] [Related]
10. Forced FOG1 expression in erythroleukemia cells: Induction of erythroid genes and repression of myelo-lymphoid transcription factor PU.1.
Fujiwara T; Sasaki K; Saito K; Hatta S; Ichikawa S; Kobayashi M; Okitsu Y; Fukuhara N; Onishi Y; Harigae H
Biochem Biophys Res Commun; 2017 Apr; 485(2):380-387. PubMed ID: 28216155
[TBL] [Abstract][Full Text] [Related]
11. SCL assembles a multifactorial complex that determines glycophorin A expression.
Lahlil R; Lécuyer E; Herblot S; Hoang T
Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
[TBL] [Abstract][Full Text] [Related]
12. Role of transcriptional corepressor ETO2 in erythroid cells.
Fujiwara T; Alqadi YW; Okitsu Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Mar; 41(3):303-15.e1. PubMed ID: 23127762
[TBL] [Abstract][Full Text] [Related]
13. Ldb1 complexes: the new master regulators of erythroid gene transcription.
Love PE; Warzecha C; Li L
Trends Genet; 2014 Jan; 30(1):1-9. PubMed ID: 24290192
[TBL] [Abstract][Full Text] [Related]
14. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish.
Patterson LJ; Gering M; Eckfeldt CE; Green AR; Verfaillie CM; Ekker SC; Patient R
Blood; 2007 Mar; 109(6):2389-98. PubMed ID: 17090656
[TBL] [Abstract][Full Text] [Related]
15. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation.
Song SH; Kim A; Ragoczy T; Bender MA; Groudine M; Dean A
Blood; 2010 Sep; 116(13):2356-64. PubMed ID: 20570862
[TBL] [Abstract][Full Text] [Related]
16. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
17. Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors.
Landry JR; Bonadies N; Kinston S; Knezevic K; Wilson NK; Oram SH; Janes M; Piltz S; Hammett M; Carter J; Hamilton T; Donaldson IJ; Lacaud G; Frampton J; Follows G; Kouskoff V; Göttgens B
Blood; 2009 Jun; 113(23):5783-92. PubMed ID: 19171877
[TBL] [Abstract][Full Text] [Related]
18. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
Gering M; Yamada Y; Rabbitts TH; Patient RK
Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
[TBL] [Abstract][Full Text] [Related]
19. SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.
Hoang T; Lambert JA; Martin R
Curr Top Dev Biol; 2016; 118():163-204. PubMed ID: 27137657
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]